A citation-based method for searching scientific literature

Joan L Kramer, Isela A Velazquez, Bingshu E Chen, Philip S Rosenberg, Jeffery P Struewing, Mark H Greene. J Clin Oncol 2005
Times Cited: 97

M C King, S Wieand, K Hale, M Lee, T Walsh, K Owens, J Tait, L Ford, B K Dunn, J Costantino, L Wickerham, N Wolmark, B Fisher. JAMA 2001
Times Cited: 504

List of shared articles

Times cited

Cancer risks for BRCA1 and BRCA2 mutation carriers: results from prospective analysis of EMBRACE.
Nasim Mavaddat, Susan Peock, Debra Frost, Steve Ellis, Radka Platte, Elena Fineberg, D Gareth Evans, Louise Izatt, Rosalind A Eeles, Julian Adlard,[...]. J Natl Cancer Inst 2013

The Role of Risk-Reducing Surgery in Hereditary Breast and Ovarian Cancer.
Lynn C Hartmann, Noralane M Lindor. N Engl J Med 2016

Local approaches to hereditary breast cancer.
B T Cooper, J O Murphy, V Sacchini, S C Formenti. Ann Oncol 2013

New insights into breast cancer genetics and impact on patient management.
Diana S Rosman, Virginia Kaklamani, Boris Pasche. Curr Treat Options Oncol 2007

Risk-reducing strategies for women carrying BRCA1/2 mutations with a focus on prophylactic surgery.
Mohamed Salhab, Selina Bismohun, Kefah Mokbel. BMC Womens Health 2010

Management of hereditary breast and ovarian cancer.
Hideko Yamauchi, Junko Takei. Int J Clin Oncol 2018

Spectrum of mutations in BRCA1, BRCA2, CHEK2, and TP53 in families at high risk of breast cancer.
Tom Walsh, Silvia Casadei, Kathryn Hale Coats, Elizabeth Swisher, Sunday M Stray, Jake Higgins, Kevin C Roach, Jessica Mandell, Ming K Lee, Sona Ciernikova,[...]. JAMA 2006

Risk-reducing salpingo-oophorectomy and breast cancer incidence among Jewish BRCA1/BRCA2-mutation carriers-an Israeli matched-pair study.
Tamar Perri, Gabriel Levin, Shani Naor-Revel, Perry Eliassi-Revivo, Dror Lifshitz, Eitan Friedman, Jacob Korach. Int J Gynaecol Obstet 2021

Survival analysis of cancer risk reduction strategies for BRCA1/2 mutation carriers.
Allison W Kurian, Bronislava M Sigal, Sylvia K Plevritis. J Clin Oncol 2010

Tolerability of breast ductal lavage in women from families at high genetic risk of breast cancer.
Jennifer T Loud, Ellen Burke Beckjord, Kathryn Nichols, June Peters, Ruthann Giusti, Mark H Greene. BMC Womens Health 2009

Online tool to guide decisions for BRCA1/2 mutation carriers.
Allison W Kurian, Diego F Munoz, Peter Rust, Elizabeth A Schackmann, Michael Smith, Lauren Clarke, Meredith A Mills, Sylvia K Plevritis. J Clin Oncol 2012

Breast cancer prevention in BRCA1/2 mutation carriers: a qualitative review.
Sarah Fuller, Fabienne Liebens, Birgit Carly, Anne Pastijn, Serge Rozenberg. Breast J 2008

A comprehensive approach to the identification and management of the BRCA patient.
Christine Garcia, C Bethan Powell. Obstet Gynecol Surv 2015

Ductal lavage in women from BRCA1/2 families: is there a future for ductal lavage in women at increased genetic risk of breast cancer?
Jennifer T Loud, Anne C M ThiĆ©baut, Andrea D Abati, Armando C Filie, Kathryn Nichols, David Danforth, Ruthann Giusti, Sheila A Prindiville, Mark H Greene. Cancer Epidemiol Biomarkers Prev 2009

Cancer risk assessment for the primary care physician.
Larissa A Korde, Shahinaz M Gadalla. Prim Care 2009

Bilateral Salpingo-oophorectomy and Breast Cancer Risk for BRCA1 and BRCA2 Mutation Carriers: Assessing the Evidence.
Ciara Conduit, Roger L Milne, Michael L Friedlander, Kelly-Anne Phillips. Cancer Prev Res (Phila) 2021

Individualized preventive and therapeutic management of hereditary breast ovarian cancer syndrome.
Dimitrios H Roukos, Evangelos Briasoulis. Nat Clin Pract Oncol 2007

Clinical management of hereditary breast cancer syndromes.
Amy S Clark, Susan M Domchek. J Mammary Gland Biol Neoplasia 2011

Prospective study of breast MRI in BRCA1 and BRCA2 mutation carriers: effect of mutation status on cancer incidence.
P Shah, M Rosen, J Stopfer, J Siegfried, R Kaltman, B Mason, K Armstrong, K L Nathanson, M Schnall, S M Domchek. Breast Cancer Res Treat 2009

The prevention of hereditary breast cancer.
Estelamari Rodriquez, Susan M Domchek. Semin Oncol 2007

Development and evaluation of a decision aid for BRCA carriers with breast cancer.
Julie O Culver, Deborah J MacDonald, Andrea A Thornton, Sharon R Sand, Marcia Grant, Deborah J Bowen, Harry Burke, Nellie Garcia, Kelly A Metcalfe, Jeffrey N Weitzel. J Genet Couns 2011

The clinical management of BRCA1 and BRCA2 mutation carriers.
Anthony P Gulati, Susan M Domchek. Curr Oncol Rep 2008

Association between clinical characteristics and risk-reduction interventions in women who underwent BRCA1 and BRCA2 testing: a single-institution study.
Anne Uyei, Susan K Peterson, Julie Erlichman, Kristine Broglio, Sandra Yekell, Kathkeen Schmeler, Karen Lu, Funda Meric-Bernstam, Chris Amos, Louise Strong,[...]. Cancer 2006

Risk-reducing salpingo-oophorectomy for the prevention of BRCA1- and BRCA2-associated breast and gynecologic cancer: a multicenter, prospective study.
Noah D Kauff, Susan M Domchek, Tara M Friebel, Mark E Robson, Johanna Lee, Judy E Garber, Claudine Isaacs, D Gareth Evans, Henry Lynch, Rosalind A Eeles,[...]. J Clin Oncol 2008